BeiGene Research Development from 2010 to 2026

ONC Stock   320.35  0.05  0.02%   
BeiGene's Research Development is increasing over the years with slightly volatile fluctuation. Overall, Research Development is expected to go to about 2.4 B this year. During the period from 2010 to 2026 BeiGene Research Development annual values regression line had geometric mean of  244,413,111 and mean square error of 67401.1 T. View All Fundamentals
 
Research Development  
First Reported
2014-03-31
Previous Quarter
524.9 M
Current Value
523.7 M
Quarterly Volatility
188.1 M
 
Yuan Drop
 
Covid
Check BeiGene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BeiGene's main balance sheet or income statement drivers, such as Depreciation And Amortization of 207.4 M, Interest Expense of 63.4 M or Selling General Administrative of 2.2 B, as well as many indicators such as Price To Sales Ratio of 0.67, Dividend Yield of 0.0 or PTB Ratio of 0.61. BeiGene financial statements analysis is a perfect complement when working with BeiGene Valuation or Volatility modules.
  
Build AI portfolio with BeiGene Stock
Check out the analysis of BeiGene Correlation against competitors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

Latest BeiGene's Research Development Growth Pattern

Below is the plot of the Research Development of BeiGene over the last few years. It is BeiGene's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BeiGene's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

BeiGene Research Development Regression Statistics

Arithmetic Mean872,868,468
Geometric Mean244,413,111
Coefficient Of Variation101.42
Mean Deviation785,387,790
Median679,005,000
Standard Deviation885,304,602
Sample Variance783764.2T
Range2.3B
R-Value0.96
Mean Square Error67401.1T
R-Squared0.92
Slope168,100,773
Total Sum of Squares12540227.8T

BeiGene Research Development History

20262.4 B
20252.2 B
2024B
20231.8 B
20221.6 B
20211.5 B
20201.3 B

About BeiGene Financial Statements

BeiGene stakeholders use historical fundamental indicators, such as BeiGene's Research Development, to determine how well the company is positioned to perform in the future. Although BeiGene investors may analyze each financial statement separately, they are all interrelated. For example, changes in BeiGene's assets and liabilities are reflected in the revenues and expenses on BeiGene's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BeiGene. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development2.2 B2.4 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether BeiGene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BeiGene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Beigene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Beigene Stock:
Check out the analysis of BeiGene Correlation against competitors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.51
Revenue Per Share
45.987
Quarterly Revenue Growth
0.41
Return On Assets
0.0169
Return On Equity
0.0181
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.